Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre -including this research content -immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
Solomon Habtemariam Pharmacognosy Research Laboratories and Herbal Analysis
References
Hoffmann, Kleine-Weber, Schroeder, Krüger, Herrler et al., SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell,
doi:10.1016/j.cell.2020.02.052Iwata-Yoshikawa, Okamura, Shimizu, Hasegawa, Takeda et al., TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection, J. Virol
Limburg, Harbig, Bestle, Stein, Moulton et al., TMPRSS2 is the major activating protease of influenza A virus in primary human airway cells and influenza B virus in human type II pneumocytes, J. Virol
Lukassen, Chua, Trefzer, Kahn, Schneider et al., SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells, EMBO J,
doi:10.15252/embj.2020105114Matsuyama, Nao, Shirato, Kawase, Saito et al., Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells, Proc. Natl. Acad. Sci,
doi:10.1073/pnas.2002589117Shen, Mao, Wu, Tanaka, Zhang, TMPRSS2: a potential target for treatment of influenza virus and coronavirus infections, Biochimie
Zmora, Hoffmann, Kollmus, Moldenhauer, Danov et al., TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1, J. Biol. Chem
DOI record:
{
"DOI": "10.1016/j.phrs.2020.104853",
"ISSN": [
"1043-6618"
],
"URL": "http://dx.doi.org/10.1016/j.phrs.2020.104853",
"alternative-id": [
"S1043661820311610"
],
"article-number": "104853",
"assertion": [
{
"label": "This article is maintained by",
"name": "publisher",
"value": "Elsevier"
},
{
"label": "Article Title",
"name": "articletitle",
"value": "Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2"
},
{
"label": "Journal Title",
"name": "journaltitle",
"value": "Pharmacological Research"
},
{
"label": "CrossRef DOI link to publisher maintained version",
"name": "articlelink",
"value": "https://doi.org/10.1016/j.phrs.2020.104853"
},
{
"label": "Content Type",
"name": "content_type",
"value": "simple-article"
},
{
"label": "Copyright",
"name": "copyright",
"value": "© 2020 Elsevier Ltd. All rights reserved."
}
],
"author": [
{
"ORCID": "http://orcid.org/0000-0001-6743-2244",
"affiliation": [],
"authenticated-orcid": false,
"family": "Habtemariam",
"given": "Solomon",
"sequence": "first"
},
{
"affiliation": [],
"family": "Nabavi",
"given": "Seyed Fazel",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0001-5948-508X",
"affiliation": [],
"authenticated-orcid": false,
"family": "Ghavami",
"given": "Saeid",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0001-5716-8101",
"affiliation": [],
"authenticated-orcid": false,
"family": "Cismaru",
"given": "Cosmin Andrei",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Berindan-Neagoe",
"given": "Ioana",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Nabavi",
"given": "Seyed Mohammad",
"sequence": "additional"
}
],
"container-title": "Pharmacological Research",
"container-title-short": "Pharmacological Research",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"elsevier.com",
"sciencedirect.com"
]
},
"created": {
"date-parts": [
[
2020,
4,
30
]
],
"date-time": "2020-04-30T17:12:44Z",
"timestamp": 1588266764000
},
"deposited": {
"date-parts": [
[
2020,
12,
4
]
],
"date-time": "2020-12-04T23:56:37Z",
"timestamp": 1607126197000
},
"indexed": {
"date-parts": [
[
2024,
3,
19
]
],
"date-time": "2024-03-19T12:27:45Z",
"timestamp": 1710851265320
},
"is-referenced-by-count": 30,
"issued": {
"date-parts": [
[
2020,
7
]
]
},
"language": "en",
"license": [
{
"URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2020,
7,
1
]
],
"date-time": "2020-07-01T00:00:00Z",
"timestamp": 1593561600000
}
}
],
"link": [
{
"URL": "https://api.elsevier.com/content/article/PII:S1043661820311610?httpAccept=text/xml",
"content-type": "text/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://api.elsevier.com/content/article/PII:S1043661820311610?httpAccept=text/plain",
"content-type": "text/plain",
"content-version": "vor",
"intended-application": "text-mining"
}
],
"member": "78",
"original-title": [],
"page": "104853",
"prefix": "10.1016",
"published": {
"date-parts": [
[
2020,
7
]
]
},
"published-print": {
"date-parts": [
[
2020,
7
]
]
},
"publisher": "Elsevier BV",
"reference": [
{
"DOI": "10.1016/j.biochi.2017.07.016",
"article-title": "TMPRSS2: a potential target for treatment of influenza virus and coronavirus infections",
"author": "Shen",
"doi-asserted-by": "crossref",
"first-page": "1",
"journal-title": "Biochimie",
"key": "10.1016/j.phrs.2020.104853_bib0005",
"volume": "142",
"year": "2017"
},
{
"DOI": "10.1128/JVI.01815-18",
"article-title": "TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection",
"author": "Iwata-Yoshikawa",
"doi-asserted-by": "crossref",
"first-page": "e01815",
"journal-title": "J. Virol.",
"key": "10.1016/j.phrs.2020.104853_bib0010",
"volume": "93",
"year": "2019"
},
{
"DOI": "10.1073/pnas.2002589117",
"article-title": "Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells",
"author": "Matsuyama",
"doi-asserted-by": "crossref",
"journal-title": "Proc. Natl. Acad. Sci. U. S. A.",
"key": "10.1016/j.phrs.2020.104853_bib0015",
"year": "2020"
},
{
"DOI": "10.1016/j.cell.2020.02.052",
"article-title": "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor",
"author": "Hoffmann",
"doi-asserted-by": "crossref",
"journal-title": "Cell",
"key": "10.1016/j.phrs.2020.104853_bib0020",
"year": "2020"
},
{
"DOI": "10.15252/embj.20105114",
"article-title": "SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells",
"author": "Lukassen",
"doi-asserted-by": "crossref",
"journal-title": "EMBO J.",
"key": "10.1016/j.phrs.2020.104853_bib0025",
"year": "2020"
},
{
"DOI": "10.1074/jbc.RA118.001273",
"article-title": "TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1",
"author": "Zmora",
"doi-asserted-by": "crossref",
"first-page": "13863",
"journal-title": "J. Biol. Chem.",
"key": "10.1016/j.phrs.2020.104853_bib0030",
"volume": "293",
"year": "2018"
},
{
"DOI": "10.1128/JVI.00649-19",
"article-title": "TMPRSS2 is the major activating protease of influenza A virus in primary human airway cells and influenza B virus in human type II pneumocytes",
"author": "Limburg",
"doi-asserted-by": "crossref",
"first-page": "e00649",
"journal-title": "J. Virol.",
"key": "10.1016/j.phrs.2020.104853_bib0035",
"volume": "93",
"year": "2019"
}
],
"reference-count": 7,
"references-count": 7,
"relation": {},
"resource": {
"primary": {
"URL": "https://linkinghub.elsevier.com/retrieve/pii/S1043661820311610"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2",
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy",
"volume": "157"
}
